• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Tuesday, January 19, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Researchers find a potential signature of cognitive function in people living with HIV

Bioengineer by Bioengineer
September 25, 2016
in Health
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

UH researchers have identified a unique epigenetic footprint in specific types of immune cells from blood that can identify individuals with HIV that have a range of impairments in cognitive function.

Credit: Wikimedia
Credit: Wikimedia

Reliable biomarkers such as that identified by the researchers offer insight into how HIV-associated cognitive impairment develops but also promises improved diagnostic testing and improved treatment decisions.

The findings are published in the scientific journal Nature Scientific Reports (September 2016) by UH Mānoa scientists Lishomwa Ndhlovu, MD, PhD, and Alika Maunakea, PhD, at the John A. Burns School of Medicine (JABSOM) and collaborators at UHM and the University of California San Francisco.

“These results offer the first significant window into the mechanisms driving HIV-related brain damage and how to track the disease,” said Dr. Ndhlovu, Associate Professor in JABSOM’s Department of Tropical Medicine.

Combination antiretroviral therapies have improved HIV survival. If started early and taken daily for life, antiretroviral therapies can result in fewer non-AIDS related complications. However, HIV still impacts the brain. Around 40% of individuals even on antiretroviral therapy still suffer HIV-related neurocognitive disorders that can affect living activities.

It has long been suspected that changes to cells of the monocyte/macrophage lineage, a type of immune cell, influence the development of cognitive impairment in HIV. Since HIV infection itself alters epigenetic processes in the immune system, the research team wondered whether a distinct DNA methylation profile, a major epigenetic modification where methyl groups are added to DNA, occurs in those with HIV associated-cognitive impairment and whether it exists in distinct immune cell populations from the blood.

By evaluating DNA methylation, the researchers discovered differences in gene networks and gene expression linked to the central nervous system and interactions with HIV that appeared uniquely in monocytes of HIV infected study participants with cognitive impairment.

“Strikingly, further analysis showed a strong association between DNA methylation levels of these markers in monocytes and neuropsychological test function, measured using a composite score of multiple cognitive domains,” said Dr. Maunakea, Assistant Professor, Department of Native Hawaiian Health, JABSOM and co-senior author of the study.

According to Michael Corley, PhD, a junior researcher in the Department of Native Hawaiian Health at JABSOM and lead author of the study, the field of epigenetics has ushered in a new era of discovery in immunology and neuroscience. “Combined with the advancement of DNA sequencing technologies to capture epigenetic profiles in unique clinical samples, researchers can make discoveries that were previously not possible,” said Dr. Corley.

Currently there is no treatment for individuals with HIV associated cognitive impairment. “The advancement in epigenetic therapeutics also affords promising new interventions that should be considered for the management of HIV associated cognitive impairment, provided they are selective to the appropriate immune cell target,” added Dr. Ndhlovu.

“There is still much we need to understand about how HIV affects the brain and several findings from this study are highly relevant to this field of NeuroAIDS,” said Dr. Ndhlovu.

Web Source: University of Hawaii at Manoa.

Reference List:

Glen M. Chew, Tsuyoshi Fujita, Gabriela M. Webb, Benjamin J. Burwitz, Helen L. Wu, Jason S. Reed, Katherine B. Hammond, Kiera L. Clayton, Naoto Ishii, Mohamed Abdel-Mohsen, Teri Liegler, Brooks I. Mitchell, Frederick M. Hecht, Mario Ostrowski, Cecilia M. Shikuma, Scott G. Hansen, Mark Maurer, Alan J. Korman, Steven G. Deeks, Jonah B. Sacha, Lishomwa C. Ndhlovu. TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection. PLOS Pathogens, 2016; 12 (1): e1005349 DOI: 10.1371/journal.ppat.1005349

The post Researchers find a potential signature of cognitive function in people living with HIV appeared first on Scienmag.

Share30Tweet7Share2ShareShareShare1

Related Posts

IMAGE

Genome editing to treat human retinal degeneration

January 19, 2021
IMAGE

Individual and organizational capacity to change can reduce health care workforce burnout

January 19, 2021

Brain cell network supplies neurons with energy

January 19, 2021

Lack of physical exercise during COVID-19 confinement may lead to a rise in mortality

January 19, 2021
Next Post
blank

Unique molecular atlas of pancreas produced

blank

Can nicotine protect the aging brain?

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    The map of nuclear deformation takes the form of a mountain landscape

    54 shares
    Share 22 Tweet 14
  • Blood pressure drug may be key to increasing lifespan, new study shows

    44 shares
    Share 18 Tweet 11
  • New drug form may help treat osteoporosis, calcium-related disorders

    40 shares
    Share 16 Tweet 10
  • People living with HIV face premature heart disease and barriers to care

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

MaterialsPublic HealthClimate ChangeChemistry/Physics/Materials SciencesBiologyInfectious/Emerging DiseasesMedicine/HealthTechnology/Engineering/Computer ScienceEcology/EnvironmentGeneticscancerCell Biology

Recent Posts

  • Genome editing to treat human retinal degeneration
  • Do simulations represent the real world at the atomic scale?
  • Protected areas vulnerable to growing emphasis on food security
  • Constructing termite turrets without a blueprint
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In